It's the second time in less than three months that the Waltham-based life sciences firm has announced layoffs.
Thermo Fisher Scientific Inc. closed 8.79% below its 52-week high of $627.88, which the company reached on September 10th.
EPS: US$16.58 (up from US$15.53 in FY 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period ...
Thermo Fisher Scientific Inc. (NYSE:TMO), a leading player in the Life Science Tools & Diagnostics sector, has been navigating a complex market landscape characterized by both challenges and ...
AbbVie, Danaher, Vertex Pharmaceuticals, Cencora, GSK, Thermo Fisher Scientific, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks ...
We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Thermo Fisher Scientific Inc. (NYSE:TMO) stands against ...
Schneider Electric, today announced continued progress toward decarbonization for the pharmaceutical and healthcare sectors.
Despite recent evidence of its financial turnaround, Thermo Fisher’s layoff spree will continue into 2025. | Despite recent ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $654.0, with a high estimate of $680.00 and a low estimate of $605.00. Experiencing a 1.36% ...
(RTTNews) - Thermo Fisher Scientific (TMO) Tuesday announced that it has entered a 10-year virtual power purchasing agreement with international renewable energy developer X-ELIO. This collaboration ...
Thermo Fisher Scientific TMO has outperformed the market over the past 10 years by 5.75% on an annualized basis producing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results